Cargando…

Do frontline health care providers know enough about artemisinin–based combination therapy to rationally treat malaria? A cross-sectional survey in Gezira State, Sudan

BACKGROUND: In 2004, artemisinin-based combination therapy (ACT) was introduced in Sudan for the treatment of malaria. The role of health care providers working in first-level health care facilities is central for the effective implementation of this revised malaria treatment policy. However, inform...

Descripción completa

Detalles Bibliográficos
Autores principales: Mannan, Abeer A, Elmardi, Khalid A, Idris, Yassir A, Spector, Jonathan M, Ali, Nahid A, Malik, Elfatih M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377190/
https://www.ncbi.nlm.nih.gov/pubmed/25889428
http://dx.doi.org/10.1186/s12936-015-0652-0
_version_ 1782363863276060672
author Mannan, Abeer A
Elmardi, Khalid A
Idris, Yassir A
Spector, Jonathan M
Ali, Nahid A
Malik, Elfatih M
author_facet Mannan, Abeer A
Elmardi, Khalid A
Idris, Yassir A
Spector, Jonathan M
Ali, Nahid A
Malik, Elfatih M
author_sort Mannan, Abeer A
collection PubMed
description BACKGROUND: In 2004, artemisinin-based combination therapy (ACT) was introduced in Sudan for the treatment of malaria. The role of health care providers working in first-level health care facilities is central for the effective implementation of this revised malaria treatment policy. However, information about their level of ACT knowledge is inadequate. This study sought to describe frontline health care providers’ knowledge about the formulations and dose regimens of nationally recommended ACT in Sudan. METHODS: This cross-sectional study took place in Gezira State, Sudan. Data were gathered from five localities comprising forty primary health care facilities. A total of 119 health care providers participated in the study (72 prescribers and 47 dispensers). The primary outcome was the proportion of health care providers who were ACT knowledgeable, a composite indicator of health care providers’ ability to (1) define what combination therapy is; (2) identify the recommended first- and second-line treatments; and (3) correctly state the dose regimens for each. RESULTS: All prescribers and 95.7% (46/47) of dispensers were aware of the new national malaria treatment policy. However, 93.1% (67/72) of prescribers compared to 87.2% (41/47) of dispensers recognized artesunate-sulphadoxine/pyrimethamine as the recommended first-line treatment in Sudan. Only a small number of prescribers and dispensers (9.4% and 13.6%, respectively) were able to correctly define the meaning of a combination therapy. Overall, only 22% (26/119, 95% CI 14.6-29.4) of health care providers were found to be ACT knowledgeable with no statistically significant difference between prescribers and dispensers. CONCLUSION: Overall, ACT knowledge among frontline health care providers is very poor. This finding suggests that efforts are needed to improve knowledge of prescribers and dispensers working in first-level health care facilities, perhaps through implementing focused, provider-oriented training programmes. Additionally, a system for regularly monitoring and evaluating the quality of in-service training may be beneficial to ensure its responsiveness to the needs of the target health care providers.
format Online
Article
Text
id pubmed-4377190
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43771902015-03-30 Do frontline health care providers know enough about artemisinin–based combination therapy to rationally treat malaria? A cross-sectional survey in Gezira State, Sudan Mannan, Abeer A Elmardi, Khalid A Idris, Yassir A Spector, Jonathan M Ali, Nahid A Malik, Elfatih M Malar J Research BACKGROUND: In 2004, artemisinin-based combination therapy (ACT) was introduced in Sudan for the treatment of malaria. The role of health care providers working in first-level health care facilities is central for the effective implementation of this revised malaria treatment policy. However, information about their level of ACT knowledge is inadequate. This study sought to describe frontline health care providers’ knowledge about the formulations and dose regimens of nationally recommended ACT in Sudan. METHODS: This cross-sectional study took place in Gezira State, Sudan. Data were gathered from five localities comprising forty primary health care facilities. A total of 119 health care providers participated in the study (72 prescribers and 47 dispensers). The primary outcome was the proportion of health care providers who were ACT knowledgeable, a composite indicator of health care providers’ ability to (1) define what combination therapy is; (2) identify the recommended first- and second-line treatments; and (3) correctly state the dose regimens for each. RESULTS: All prescribers and 95.7% (46/47) of dispensers were aware of the new national malaria treatment policy. However, 93.1% (67/72) of prescribers compared to 87.2% (41/47) of dispensers recognized artesunate-sulphadoxine/pyrimethamine as the recommended first-line treatment in Sudan. Only a small number of prescribers and dispensers (9.4% and 13.6%, respectively) were able to correctly define the meaning of a combination therapy. Overall, only 22% (26/119, 95% CI 14.6-29.4) of health care providers were found to be ACT knowledgeable with no statistically significant difference between prescribers and dispensers. CONCLUSION: Overall, ACT knowledge among frontline health care providers is very poor. This finding suggests that efforts are needed to improve knowledge of prescribers and dispensers working in first-level health care facilities, perhaps through implementing focused, provider-oriented training programmes. Additionally, a system for regularly monitoring and evaluating the quality of in-service training may be beneficial to ensure its responsiveness to the needs of the target health care providers. BioMed Central 2015-03-26 /pmc/articles/PMC4377190/ /pubmed/25889428 http://dx.doi.org/10.1186/s12936-015-0652-0 Text en © Mannan et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mannan, Abeer A
Elmardi, Khalid A
Idris, Yassir A
Spector, Jonathan M
Ali, Nahid A
Malik, Elfatih M
Do frontline health care providers know enough about artemisinin–based combination therapy to rationally treat malaria? A cross-sectional survey in Gezira State, Sudan
title Do frontline health care providers know enough about artemisinin–based combination therapy to rationally treat malaria? A cross-sectional survey in Gezira State, Sudan
title_full Do frontline health care providers know enough about artemisinin–based combination therapy to rationally treat malaria? A cross-sectional survey in Gezira State, Sudan
title_fullStr Do frontline health care providers know enough about artemisinin–based combination therapy to rationally treat malaria? A cross-sectional survey in Gezira State, Sudan
title_full_unstemmed Do frontline health care providers know enough about artemisinin–based combination therapy to rationally treat malaria? A cross-sectional survey in Gezira State, Sudan
title_short Do frontline health care providers know enough about artemisinin–based combination therapy to rationally treat malaria? A cross-sectional survey in Gezira State, Sudan
title_sort do frontline health care providers know enough about artemisinin–based combination therapy to rationally treat malaria? a cross-sectional survey in gezira state, sudan
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377190/
https://www.ncbi.nlm.nih.gov/pubmed/25889428
http://dx.doi.org/10.1186/s12936-015-0652-0
work_keys_str_mv AT mannanabeera dofrontlinehealthcareprovidersknowenoughaboutartemisininbasedcombinationtherapytorationallytreatmalariaacrosssectionalsurveyingezirastatesudan
AT elmardikhalida dofrontlinehealthcareprovidersknowenoughaboutartemisininbasedcombinationtherapytorationallytreatmalariaacrosssectionalsurveyingezirastatesudan
AT idrisyassira dofrontlinehealthcareprovidersknowenoughaboutartemisininbasedcombinationtherapytorationallytreatmalariaacrosssectionalsurveyingezirastatesudan
AT spectorjonathanm dofrontlinehealthcareprovidersknowenoughaboutartemisininbasedcombinationtherapytorationallytreatmalariaacrosssectionalsurveyingezirastatesudan
AT alinahida dofrontlinehealthcareprovidersknowenoughaboutartemisininbasedcombinationtherapytorationallytreatmalariaacrosssectionalsurveyingezirastatesudan
AT malikelfatihm dofrontlinehealthcareprovidersknowenoughaboutartemisininbasedcombinationtherapytorationallytreatmalariaacrosssectionalsurveyingezirastatesudan